ADRB2 and chronic myelogenous leukemia, BCR-ABL1 positive: Several elevated ligand-receptor pairs in CML were related to cancer development, such as ADRB2_VEGFB, which was involved in tumor angiogenesis,39 and BTLA_TNFRSF14, which was reported in immune regulation.40